Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort
Yoon-Kyo An, Niamh Lindsay, Natalie Allan, Emi Khoo, Anna Amiss, Md Moniruzzaman, Richard Fernandes, S-Y Ooi, Lena Thin, Daniel Lightowler, Susan Connor, Astrid-Jane Williams, Peter De Cruz, Christopher Li Wai Suen, Viraj Kariyawasam, Nicola Mitrev, Simon Ghaly, Jane M. Andrews, Britt Christensen, Miles P. SparrowLauren White, Robert Bryant, Nik Ding, Rupert W. Leong, Daniel van Langenberg, Hans Seltenreich, Kavitha Subramaniam, Graham Radford-Smith, Jakob Begun
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
Fingerprint
Dive into the research topics of 'Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort'. Together they form a unique fingerprint.